Assessment of lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate in a real clinical setting

被引：0
|
作者：
Alroughani, Raed [1 ]
Ahmed, Samar [2 ]
Behbehani, Raed [2 ]
Al-hashel, Jasem [3 ]
机构：
[1] Amiri Hosp, Kuwait, Kuwait
[2] Ibn Sina Hosp, Kuwait, Kuwait
[3] Kuwait Univ, Kuwait, Kuwait
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
47
引用
收藏
页码：NP18 / NP18
页数：1
相关论文
共 50 条
  • [1] Assessment of lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate in a real clinical setting
    Alroughani, R.
    Ahmed, S.
    Behbehani, R.
    Al-Hashel, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 593 - 593
  • [2] Longitudinal Data on Lymphopenia in Multiple Sclerosis Patients Treated with Dimethyl Fumarate
    Romba, Meghan
    Wundes, Annette
    Von Geldern, Gloria
    NEUROLOGY, 2016, 86
  • [3] Predictive factors of lymphopenia in a young cohort of Multiple Sclerosis patients treated with Dimethyl Fumarate
    Krupka, Danna
    Ferreira, Vitor Mendes
    Correia, Ana Sofia
    Teixeira, Manuel Salavisa
    Serrazina, Filipa
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 971 - 971
  • [4] Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis
    Ravn, Julie
    Jensen, Henrik Boye
    Kant, Matthias
    Andersen, Preben Borring
    Gora, Monika Katarzyna
    Sejbaek, Tobias
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
  • [5] Risk factors for Development of Lymphopenia in Dimethyl Fumarate-treated Patients with Multiple Sclerosis
    Bloch, Caroline Holst
    Sejbaek, Tobias
    Kant, Matthias
    Blaabjerg, Morten
    Jensen, Henrik Boye
    Andersen, Preben
    Petersen, Annett
    Gora, Monika
    NEUROLOGY, 2019, 92 (15)
  • [6] Lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate: A single-center experience
    Dinoto, Alessandro
    Sartori, Arianna
    Cheli, Marta
    Pasquin, Fulvio
    Baldini, Sara
    Bratina, Alessio
    Bosco, Antonio
    Manganotti, Paolo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [7] Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate
    Sangurdekar, Dipen
    Sun, Chao
    McLaughlin, Helen
    Ayling-Rouse, Katherine
    Allaire, Normand E.
    Penny, Michelle A.
    Bronson, Paola G.
    FRONTIERS IN GENETICS, 2019, 10
  • [8] Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate
    Morales, Fabian Sierra
    Koralnik, Igor J.
    Gautam, Shiva
    Samaan, Soleil
    Sloane, Jacob A.
    JOURNAL OF NEUROLOGY, 2020, 267 (01) : 125 - 131
  • [9] Characterization of lymphopenia in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate and fingolimod
    Nakhaei-Nejad, M.
    Barilla, D.
    Lee, C-H.
    Blevins, G.
    Giuliani, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 618 - 618
  • [10] Correction to: Risk factors for lymphopenia in patients with relapsing–remitting multiple sclerosis treated with dimethyl fumarate
    Fabian Sierra Morales
    Igor J. Koralnik
    Shiva Gautam
    Soleil Samaan
    Jacob A. Sloane
    Journal of Neurology, 2020, 267 : 132 - 132
12345